Adrenoleukodystrophy: Molecular Genetics, Pathology, and Lorenzo's oil
- 1 July 1995
- journal article
- review article
- Published by Wiley in Brain Pathology
- Vol. 5 (3) , 259-266
- https://doi.org/10.1111/j.1750-3639.1995.tb00602.x
Abstract
Knowledge about adrenoleukodystrophy (ALD), a disorder which was described first in 1923, has increased greatly during recent years. The principal biochemical abnormality, the presumed enzyme defect, and the gene defect, have been defined. A dietary therapy has been proposed and attracted world-wide attention through a motion picture. Nevertheless, many questions remain and cannot be answered without a more fundamental understanding of pathology and pathogenesis. This article will provide a review of the history, clinical features, pathology, biochemistry, and the gene defect, and then appraise current efforts to clarify pathogenesis and develop therapeutic approaches.Keywords
This publication has 60 references indexed in Scilit:
- X-Linked Adrenoleukodystrophy (ALD): A Novel Mutation of the ALD Gene in 6 Members of a Family Presenting with 5 Different PhenotypesBiochemical and Biophysical Research Communications, 1994
- Identification of a Two Base Pair Deletion in Five Unrelated Families with Adrenoleukodystrophy: A Possible Hot Spot for MutationsBiochemical and Biophysical Research Communications, 1994
- Identification of a Nonsense Mutation in ALD Protein cDNA from a Patient with AdrenoleukodystrophyBiochemical and Biophysical Research Communications, 1994
- Penetrating the peroxisomeNature, 1993
- Adrenoleukodystrophy: Phenotypic variability and implications for therapyJournal of Inherited Metabolic Disease, 1992
- Clinical variation in X-linked adrenoleukodystrophy: Fatty acid and lipid metabolism in cultured fibroblastsBiochemical Medicine and Metabolic Biology, 1991
- Reversal of Early Neurologic and Neuroradiologic Manifestations of X-Linked Adrenoleukodystrophy by Bone Marrow TransplantationNew England Journal of Medicine, 1990
- Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acidsBiochemical and Biophysical Research Communications, 1988
- FATTY ACID ABNORMALITY IN ADRENOLEUKODYSTROPHYJournal of Neurochemistry, 1976
- Bronzekrankheit und sklerosierende EncephalomyelitisArchiv Fur Psychiatrie Und Nervenkrankheiten, 1923